Somasundaram Murali, Greco Karin V, Bhatnagar Gauraang, Gabe Simon, Sibbons Paul, Friend Peter, Ansari Tahera
Research and Development Department, Northwick Park Institute for Medical Research-The Griffin Institute, London HA1 3UJ, UK.
Nuffield Department of Surgical Sciences, Oxford Transplant Centre, University of Oxford, Oxford OX1 4BH, UK.
Cells. 2025 May 31;14(11):817. doi: 10.3390/cells14110817.
The rising incidence of colorectal cancer and ulcerative colitis underscores an urgent need for regenerative solutions to address functional deficits after colectomy. However, the creation of clinically applicable large intestine scaffolds remains underdeveloped. Here, we report the successful generation and thorough characterisation of transplantable-sized porcine large intestinal scaffolds via perfusion decellularisation. This method effectively preserved extracellular matrix (ECM) structural and biochemical integrity while minimising immunogenicity through cellular component removal. Crucially, native vasculature remained intact, confirmed by histology, DNA quantification, and high-resolution CT angiography. Despite efficient decellularisation, challenges including residual nucleic acids, ECM heterogeneity, and partial microvascular occlusion were noted, echoing ongoing limitations in engineered, perfusable, full-thickness scaffolds. In vivo implantation demonstrated favourable biocompatibility and host integration; however, thrombosis occurred due to the lack of pre-seeded cells, emphasising the necessity of recellularisation for functional perfusion prior to implantation. This study addresses significant field limitations, presenting the first reproducible approach for structurally intact, perfusable, full-thickness large intestinal scaffolds of transplantable dimensions. Our innovations offer a strong foundation for future integration of patient-derived cells, stem cells, and organoids, progressing toward clinically viable, scalable, tissue-engineered large intestine constructs, from xenogeneic sources, relevant for regenerative medicine, disease modelling, and pharmacological screening.
结直肠癌和溃疡性结肠炎发病率的不断上升凸显了迫切需要再生解决方案来解决结肠切除术后的功能缺陷。然而,临床上适用的大肠支架的创建仍未得到充分发展。在此,我们报告了通过灌注去细胞化成功生成并全面表征了可移植尺寸的猪大肠支架。该方法有效地保留了细胞外基质(ECM)的结构和生化完整性,同时通过去除细胞成分将免疫原性降至最低。至关重要的是,通过组织学、DNA定量和高分辨率CT血管造影证实,天然血管保持完整。尽管去细胞化有效,但仍注意到包括残留核酸、ECM异质性和部分微血管阻塞在内的挑战,这与工程化、可灌注、全层支架中持续存在的局限性相呼应。体内植入显示出良好的生物相容性和宿主整合;然而,由于缺乏预先接种的细胞而发生了血栓形成,这强调了在植入前进行再细胞化以实现功能性灌注的必要性。本研究解决了该领域的重大局限性,提出了第一种可重复的方法来制备结构完整、可灌注、全层且尺寸可移植的大肠支架。我们的创新为未来整合患者来源的细胞、干细胞和类器官奠定了坚实基础,朝着临床上可行、可扩展的组织工程大肠构建体迈进,这些构建体来自与再生医学、疾病建模和药理筛选相关的异种来源。